Related Experiment Video
Updated: Jun 28, 2026
05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Tricuspid valve replacement and levosimendan
Ferit Cicekcioglu1, Ali Ihsan Parlar, Levent Altinay
1Cardiovascular Surgery Clinic, Turkiye Yuksek Ihtisas Hospital, Ankara, Turkey.
General Thoracic and Cardiovascular Surgery
|November 13, 2008
Summary
Levosimendan use in tricuspid valve replacement surgery improved patient outcomes. This treatment effectively managed right heart failure, leading to uneventful postoperative recovery in two reported cases.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Isolated tricuspid valve replacement is a rare procedure with high complication rates.
- Right heart failure is a primary cause of adverse outcomes following tricuspid valve surgery.
- Current treatments for right heart failure may exacerbate myocardial calcium overload.
Observation:
- Levosimendan, an inodilator, was administered to two patients undergoing tricuspid valve replacement.
- Levosimendan offers inotropic and vasodilatory effects without increasing myocardial calcium.
- The administration of levosimendan was well-tolerated by both patients.
Findings:
- Both patients undergoing tricuspid valve replacement with levosimendan experienced successful operations.
- Postoperative recovery for both patients was uneventful, indicating effective management of right heart failure.
- Levosimendan demonstrated a positive impact on patient outcomes in this challenging surgical context.
Implications:
- Levosimendan may be a beneficial therapeutic option for managing right heart failure during tricuspid valve replacement.
- This approach could potentially reduce morbidity and mortality associated with tricuspid valve surgery.
- Further research is warranted to explore the broader application of levosimendan in complex cardiac surgeries.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...